US Stock MarketDetailed Quotes

DNLI Denali Therapeutics

Watchlist
  • 14.510
  • -0.930-6.02%
Close Mar 18 16:00 ET
  • 14.510
  • 0.0000.00%
Post 16:20 ET
2.11BMarket Cap-5.65P/E (TTM)

Denali Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
2.88%-347.69M
15.15%-83.72M
32.31%-59.14M
19.39%-91.22M
-93.22%-113.62M
-46.29%-357.99M
-35.77%-98.66M
-53.14%-87.36M
-163.81%-113.17M
18.45%-58.8M
Net income from continuing operations
-191.12%-422.77M
3.95%-114.75M
-7.89%-107.19M
-154.00%-99.03M
7.27%-101.8M
55.45%-145.22M
-21.07%-119.47M
3.82%-99.35M
411.91%183.38M
-68.32%-109.78M
Operating gains losses
---14.54M
--0
--0
--0
---14.54M
----
----
----
----
----
Depreciation and amortization
-46.24%8.99M
20.30%2.62M
2.35%2.27M
-15.01%1.94M
-78.48%2.16M
61.09%16.73M
-46.79%2.18M
3.55%2.22M
10.28%2.29M
383.26%10.05M
Other non cash items
-9.60%-4.07M
-9.84%-1.05M
-9.61%-1.05M
-9.81%-1.02M
-9.12%-957K
-13.05%-3.72M
-12.22%-955K
-16.85%-957K
-11.14%-928K
-12.01%-877K
Change In working capital
105.84%16.94M
80.46%10.56M
788.70%30.35M
97.39%-8.16M
-173.27%-15.81M
-1,106.52%-289.93M
792.98%5.85M
-120.95%-4.41M
-3,103.79%-312.95M
160.01%21.58M
-Change in prepaid assets
39.42%-2.48M
102.42%145K
20,257.47%17.71M
-143.47%-1.57M
-948.97%-18.77M
-48.33%-4.09M
-336.97%-6M
-99.35%87K
122.58%3.61M
-244.04%-1.79M
-Change in payables and accrued expense
270.43%18.81M
2.79%12.57M
406.08%9.87M
75.98%-6.59M
-87.43%2.96M
-61.50%5.08M
429.07%12.23M
-128.72%-3.23M
-509.23%-27.44M
433.07%23.51M
-Change in other current assets
--603K
--1.78M
----
----
----
--0
--0
----
----
----
-Change in other current liabilities
--0
----
----
----
----
---379K
----
----
----
----
-Change in other working capital
----
----
----
----
----
-743.05%-290.53M
--0
64.37%-1.27M
-60,259.71%-289.12M
99.53%-141K
Cash from discontinued investing activities
Operating cash flow
2.88%-347.69M
15.15%-83.72M
32.31%-59.14M
19.39%-91.22M
-93.22%-113.62M
-46.29%-357.99M
-35.77%-98.66M
-53.14%-87.36M
-163.81%-113.17M
18.45%-58.8M
Investing cash flow
Cash flow from continuing investing activities
-135.60%-88.76M
135.75%172.21M
-7.19%93.66M
-41.35%98.57M
-388.80%-453.19M
276.33%249.31M
157.27%73.05M
554.45%100.91M
89.63%168.07M
21.35%-92.72M
Net PPE purchase and sale
-22.98%-15.91M
-127.83%-5.09M
-87.81%-3.88M
18.19%-4.79M
22.83%-2.15M
27.44%-12.94M
53.91%-2.24M
65.82%-2.07M
-102.21%-5.85M
31.06%-2.79M
Net investment purchase and sale
-127.78%-72.84M
135.51%177.3M
-5.28%97.54M
-40.57%103.36M
-401.55%-451.04M
312.25%262.25M
161.35%75.28M
379.65%102.98M
90.02%173.92M
21.00%-89.93M
Cash from discontinued investing activities
Investing cash flow
-135.60%-88.76M
135.75%172.21M
-7.19%93.66M
-41.35%98.57M
-388.80%-453.19M
276.33%249.31M
157.27%73.05M
554.45%100.91M
89.63%168.07M
21.35%-92.72M
Financing cash flow
Cash flow from continuing financing activities
2,617.76%484.3M
-188.59%-4.17M
-844.74%-18.56M
-25.09%6.76M
31,089.21%500.28M
-94.26%17.82M
-98.43%4.71M
-51.65%2.49M
104.88%9.02M
9.64%1.6M
Net issuance payments of debt
---32.34M
---8.32M
----
----
----
--0
--0
----
----
----
Net common stock issuance
--499.25M
--0
--0
--0
--499.25M
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
-2.42%17.39M
-11.69%4.16M
118.94%5.46M
-25.09%6.76M
-36.28%1.02M
23.28%17.82M
36.93%4.71M
-51.65%2.49M
104.88%9.02M
9.64%1.6M
Cash from discontinued financing activities
Financing cash flow
2,617.76%484.3M
-188.59%-4.17M
-844.74%-18.56M
-25.09%6.76M
31,089.21%500.28M
-94.26%17.82M
-98.43%4.71M
-51.65%2.49M
104.88%9.02M
9.64%1.6M
Net cash flow
Beginning cash position
-41.39%128.68M
-38.36%92.21M
-42.90%76.25M
-10.75%62.15M
-41.39%128.68M
-25.57%219.54M
24.54%149.59M
-14.71%133.55M
-34.59%69.63M
-25.57%219.54M
Current changes in cash
152.67%47.85M
503.37%84.32M
-0.51%15.96M
-77.93%14.11M
55.62%-66.53M
-20.46%-90.86M
-121.03%-20.91M
143.97%16.04M
27.49%63.92M
20.48%-149.91M
End cash Position
37.19%176.54M
37.19%176.54M
-38.36%92.21M
-42.90%76.25M
-10.75%62.15M
-41.39%128.68M
-41.39%128.68M
24.54%149.59M
-14.71%133.55M
-34.59%69.63M
Free cash flow
1.97%-363.61M
11.98%-88.81M
29.53%-63.02M
19.34%-96.01M
-87.97%-115.77M
-41.28%-370.93M
-30.16%-100.89M
-41.74%-89.43M
-159.92%-119.02M
19.12%-61.59M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 2.88%-347.69M15.15%-83.72M32.31%-59.14M19.39%-91.22M-93.22%-113.62M-46.29%-357.99M-35.77%-98.66M-53.14%-87.36M-163.81%-113.17M18.45%-58.8M
Net income from continuing operations -191.12%-422.77M3.95%-114.75M-7.89%-107.19M-154.00%-99.03M7.27%-101.8M55.45%-145.22M-21.07%-119.47M3.82%-99.35M411.91%183.38M-68.32%-109.78M
Operating gains losses ---14.54M--0--0--0---14.54M--------------------
Depreciation and amortization -46.24%8.99M20.30%2.62M2.35%2.27M-15.01%1.94M-78.48%2.16M61.09%16.73M-46.79%2.18M3.55%2.22M10.28%2.29M383.26%10.05M
Other non cash items -9.60%-4.07M-9.84%-1.05M-9.61%-1.05M-9.81%-1.02M-9.12%-957K-13.05%-3.72M-12.22%-955K-16.85%-957K-11.14%-928K-12.01%-877K
Change In working capital 105.84%16.94M80.46%10.56M788.70%30.35M97.39%-8.16M-173.27%-15.81M-1,106.52%-289.93M792.98%5.85M-120.95%-4.41M-3,103.79%-312.95M160.01%21.58M
-Change in prepaid assets 39.42%-2.48M102.42%145K20,257.47%17.71M-143.47%-1.57M-948.97%-18.77M-48.33%-4.09M-336.97%-6M-99.35%87K122.58%3.61M-244.04%-1.79M
-Change in payables and accrued expense 270.43%18.81M2.79%12.57M406.08%9.87M75.98%-6.59M-87.43%2.96M-61.50%5.08M429.07%12.23M-128.72%-3.23M-509.23%-27.44M433.07%23.51M
-Change in other current assets --603K--1.78M--------------0--0------------
-Change in other current liabilities --0-------------------379K----------------
-Change in other working capital ---------------------743.05%-290.53M--064.37%-1.27M-60,259.71%-289.12M99.53%-141K
Cash from discontinued investing activities
Operating cash flow 2.88%-347.69M15.15%-83.72M32.31%-59.14M19.39%-91.22M-93.22%-113.62M-46.29%-357.99M-35.77%-98.66M-53.14%-87.36M-163.81%-113.17M18.45%-58.8M
Investing cash flow
Cash flow from continuing investing activities -135.60%-88.76M135.75%172.21M-7.19%93.66M-41.35%98.57M-388.80%-453.19M276.33%249.31M157.27%73.05M554.45%100.91M89.63%168.07M21.35%-92.72M
Net PPE purchase and sale -22.98%-15.91M-127.83%-5.09M-87.81%-3.88M18.19%-4.79M22.83%-2.15M27.44%-12.94M53.91%-2.24M65.82%-2.07M-102.21%-5.85M31.06%-2.79M
Net investment purchase and sale -127.78%-72.84M135.51%177.3M-5.28%97.54M-40.57%103.36M-401.55%-451.04M312.25%262.25M161.35%75.28M379.65%102.98M90.02%173.92M21.00%-89.93M
Cash from discontinued investing activities
Investing cash flow -135.60%-88.76M135.75%172.21M-7.19%93.66M-41.35%98.57M-388.80%-453.19M276.33%249.31M157.27%73.05M554.45%100.91M89.63%168.07M21.35%-92.72M
Financing cash flow
Cash flow from continuing financing activities 2,617.76%484.3M-188.59%-4.17M-844.74%-18.56M-25.09%6.76M31,089.21%500.28M-94.26%17.82M-98.43%4.71M-51.65%2.49M104.88%9.02M9.64%1.6M
Net issuance payments of debt ---32.34M---8.32M--------------0--0------------
Net common stock issuance --499.25M--0--0--0--499.25M--0--0--0--0--0
Proceeds from stock option exercised by employees -2.42%17.39M-11.69%4.16M118.94%5.46M-25.09%6.76M-36.28%1.02M23.28%17.82M36.93%4.71M-51.65%2.49M104.88%9.02M9.64%1.6M
Cash from discontinued financing activities
Financing cash flow 2,617.76%484.3M-188.59%-4.17M-844.74%-18.56M-25.09%6.76M31,089.21%500.28M-94.26%17.82M-98.43%4.71M-51.65%2.49M104.88%9.02M9.64%1.6M
Net cash flow
Beginning cash position -41.39%128.68M-38.36%92.21M-42.90%76.25M-10.75%62.15M-41.39%128.68M-25.57%219.54M24.54%149.59M-14.71%133.55M-34.59%69.63M-25.57%219.54M
Current changes in cash 152.67%47.85M503.37%84.32M-0.51%15.96M-77.93%14.11M55.62%-66.53M-20.46%-90.86M-121.03%-20.91M143.97%16.04M27.49%63.92M20.48%-149.91M
End cash Position 37.19%176.54M37.19%176.54M-38.36%92.21M-42.90%76.25M-10.75%62.15M-41.39%128.68M-41.39%128.68M24.54%149.59M-14.71%133.55M-34.59%69.63M
Free cash flow 1.97%-363.61M11.98%-88.81M29.53%-63.02M19.34%-96.01M-87.97%-115.77M-41.28%-370.93M-30.16%-100.89M-41.74%-89.43M-159.92%-119.02M19.12%-61.59M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Vale SA
VALE
+0.99%
D.R. Horton
DHI
+0.62%
Taylor Morrison Home
TMHC
-0.14%
Petroleo Brasileiro SA Petrobras
PBR
-0.14%
Ecopetrol
EC
-0.39%

Unlock the Full List